Announce Date | 05/07/2025 |
EPS Normalized Actual | $-0.14 (Beat by $0.14) |
EPS GAAP Actual | $-0.14 (Beat by $0.14) |
Revenue Actual | $0.007566B |
Revenue Surprise | Beat by $7.566M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.16667 |
EPS GAAP Estimate | $-0.16667 |
Revenue Estimate | $0.019466667B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | -0.52 | -77.12 | -0.62773 | -0.45716 | 1 |
Dec 2028 | -0.22 | -182.27 | -0.22315 | -0.21396 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.14 | 0.09 | 0.007566B | -0.21% | -7.43M |
FQ4 2024 (Dec 2024) | -0.95 | -0.95 | 0.01171B | 47.86% | 11.71M |
FQ3 2024 (Sep 2024) | -0.25 | -0.25 | 0.0124B | 50.52% | 12.4M |
FQ2 2024 (Jun 2024) | -0.18 | -0.18 | 0.011381B | 51.54% | 11.38M |
FQ1 2020 (Mar 2020) | -0.63 | -0.63 | 0B | NAN% | 0M |
FQ2 2020 (Jun 2020) | -0.68 | -0.68 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | -0.19 | -0.19 | 0.007582B | 43.48% | 7.58M |
FQ4 2023 (Dec 2023) | -0.2 | -0.2 | 0.006106B | 37.65% | 6.11M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.16667
Consensus Revenue Estimates
0.019466667B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
FQ4 2026 (Oct 2026) | -0.18 | -- | -0.18855 | -0.17673 | 0 |
FQ3 2026 (Jul 2026) | -0.19 | -- | -0.19903 | -0.18655 | 0 |
FQ2 2026 (Jun 2026) | -0.19 | -- | -0.19229 | -0.18931 | 0 |
FQ1 2026 (Mar 2026) | -0.21 | 33.33 | -0.21253 | -0.20924 | 0 |
FQ4 2025 (Oct 2025) | -0.16667 | -469.99 | -0.17459 | -0.16364 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.08B | -- | 0.08B | 0.08B | 1 |
FQ2 2027 (Jun 2027) | 0.07B | -- | 0.07B | 0.07B | 1 |
FQ1 2027 (Mar 2027) | 0.06B | -- | 0.06B | 0.06B | 1 |
FQ4 2026 (Oct 2026) | 0.04B | -- | 0.04B | 0.04B | 1 |
FQ3 2026 (Jul 2026) | 0.04B | -- | 0.04B | 0.04B | 1 |
FQ2 2026 (Jun 2026) | 0.04B | -- | 0.04B | 0.04B | 1 |
FQ1 2026 (Mar 2026) | 0.03B | 72.98 | 0.03B | 0.03B | 1 |
FQ4 2025 (Oct 2025) | 0.02B | 49.45 | 0.02B | 0.02B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
1
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.23 | -0.14 | 0.09 | -64.29% |
FQ4 2024 (Dec 2024) | -0.95 | -0.95 | 100% | |
FQ3 2024 (Sep 2024) | -0.25 | -0.25 | 100% | |
FQ2 2024 (Jun 2024) | -0.18 | -0.18 | 100% | |
FQ1 2020 (Mar 2020) | -0.63 | -0.63 | 100% | |
FQ2 2020 (Jun 2020) | -0.68 | -0.68 | 100% | |
FQ1 2024 (Mar 2024) | -0.19 | -0.19 | 100% | |
FQ4 2023 (Dec 2023) | -0.2 | -0.2 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.02B | $0.01B | $-7.43M | -98.26% |
FQ4 2024 (Dec 2024) | $0B | $0.01B | $11.71M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.01B | $12.4M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.01B | $11.38M | 100% |
FQ1 2020 (Mar 2020) | $0B | $0B | $0M | NAN% |
FQ2 2020 (Jun 2020) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $0.01B | $7.58M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.01B | $6.11M | 100% |